Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Iron Triangle Partners LP Stock Portfolio

$976Million– No. of Holdings #28

Iron Triangle Partners LP Performance:
2024 Q1: 8.61%YTD: 8.61%2023: 16.08%

Performance for 2024 Q1 is 8.61%, and YTD is 8.61%, and 2023 is 16.08%.

About Iron Triangle Partners LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Iron Triangle Partners LP reported an equity portfolio of $976.3 Millions as of 31 Mar, 2024.

The top stock holdings of Iron Triangle Partners LP are ACHC, DXCM, ICLR. The fund has invested 7.3% of it's portfolio in ACADIA HEALTHCARE COMPANY IN and 6.7% of portfolio in DEXCOM INC.

The fund managers got completely rid off UNIVERSAL HLTH SVCS INC (UHS), IDEXX LABS INC (IDXX) and SURGERY PARTNERS INC (SGRY) stocks. They significantly reduced their stock positions in ELANCO ANIMAL HEALTH INC (ELAN), MCKESSON CORP (MCK) and OSCAR HEALTH INC (OSCR). Iron Triangle Partners LP opened new stock positions in EXACT SCIENCES CORP (EXAS), WEST PHARMACEUTICAL SVSC INC (WST) and ALIGN TECHNOLOGY INC (ALGN). The fund showed a lot of confidence in some stocks as they added substantially to TEVA PHARMACEUTICAL INDS LTD (TEVA), SCHRODINGER INC (SDGR) and GLAUKOS CORP (GKOS).
Iron Triangle Partners LP Equity Portfolio Value
Last Reported on: 15 May, 2024

Iron Triangle Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Iron Triangle Partners LP made a return of 8.61% in the last quarter. In trailing 12 months, it's portfolio return was 23.56%.

New Buys

Ticker$ Bought
exact sciences corp48,342,000
west pharmaceutical svsc inc47,380,700
align technology inc46,550,900
apellis pharmaceuticals inc32,329,000
fortrea hldgs inc31,760,100
neurocrine biosciences inc30,342,400
avantor inc29,405,500
shockwave med inc25,964,400

New stocks bought by Iron Triangle Partners LP

Additions to existing portfolio by Iron Triangle Partners LP

Reductions

Ticker% Reduced
elanco animal health inc-56.76
mckesson corp-53.23
oscar health inc-34.98
908 devices inc-19.00
icon plc-12.64

Iron Triangle Partners LP reduced stake in above stock

Sold off

Ticker$ Sold
pacific biosciences calif in-18,082,600
surgery partners inc-33,414,500
sanofi-24,865,000
10x genomics inc-26,825,800
legend biotech corp-22,864,600
establishment labs hldgs inc-8,575,750
universal hlth svcs inc-49,068,300
biomarin pharmaceutical inc-19,284,000

Iron Triangle Partners LP got rid off the above stocks

Sector Distribution

Iron Triangle Partners LP has about 84% of it's holdings in Healthcare sector.

Sector%
Healthcare84
Others12.9
Basic Materials3

Market Cap. Distribution

Iron Triangle Partners LP has about 46.5% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP41.3
MID-CAP30.9
UNALLOCATED12.9
SMALL-CAP8.8
MEGA-CAP5.2

Stocks belong to which Index?

About 51.7% of the stocks held by Iron Triangle Partners LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others48.3
S&P 50033.6
RUSSELL 200018.1
Top 5 Winners (%)%
OSCR
oscar health inc
58.6 %
SWAV
shockwave med inc
29.4 %
BRKR
bruker corp
27.3 %
TEVA
teva pharmaceutical inds ltd
20.2 %
ISRG
intuitive surgical inc
17.7 %
Top 5 Winners ($)$
OSCR
oscar health inc
11.0 M
BRKR
bruker corp
9.4 M
ISRG
intuitive surgical inc
7.5 M
DXCM
dexcom inc
7.3 M
ABBV
abbvie inc
6.9 M
Top 5 Losers (%)%
MASS
908 devices inc
-33.3 %
SDGR
schrodinger inc
-15.0 %
CYTK
cytokinetics inc
-8.9 %
APLS
apellis pharmaceuticals inc
-7.1 %
ILMN
illumina inc
-1.1 %
Top 5 Losers ($)$
MASS
908 devices inc
-4.8 M
SDGR
schrodinger inc
-4.1 M
APLS
apellis pharmaceuticals inc
-2.5 M
CYTK
cytokinetics inc
-2.0 M
ILMN
illumina inc
-0.5 M

Iron Triangle Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Iron Triangle Partners LP

Iron Triangle Partners LP has 28 stocks in it's portfolio. About 53.2% of the portfolio is in top 10 stocks. MASS proved to be the most loss making stock for the portfolio. OSCR was the most profitable stock for Iron Triangle Partners LP last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions